5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy

Histopathological correlates with survival in reoperated glioblastomas

(2013) Graeme F. Woodworth et al.   JOURNAL OF NEURO-ONCOLOGY

Proof of principle: supramarginal resection of cerebral metastases in eloquent brain areas

(2012) Marcel A. Kamp et al.   ACTA NEUROCHIRURGICA

5-Aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study

(2011) Marcel A. Kamp et al.   ACTA NEUROCHIRURGICA

Early post-treatment pseudo-progression amongst glioblastoma multiforme patients treated with radiotherapy and temozolomide: A retrospective analysis

(2011) Ashray Gunjur et al.   Journal of Medical Imaging and Radiation Oncology

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

The importance of surgical resection in malignant glioma

(2009) Walter Stummer et al.   CURRENT OPINION IN NEUROLOGY

FIVE-AMINOLEVULINIC ACID FOR FLUORESCENCE-GUIDED RESECTION OF RECURRENT MALIGNANT GLIOMAS

(2009) Arya Nabavi et al.   NEUROSURGERY

Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations

(2009) Cristo Chaskis et al.   SURGICAL NEUROLOGY

Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

(2008) Walter Taal et al.   CANCER

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

(2008) Dieta Brandsma et al.   LANCET ONCOLOGY

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology

(2008) Alba A. Brandes et al.   NEURO-ONCOLOGY